Shows / New Retina Radio by Eyetube
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Episodes
New Retina Radio by EyetubeNew Retina Radio Journal Club: Are Postpartum Retinal Detachment Rates Linked to Method of Delivery?
Do patients with a history of retinal detachment (RD) experience higher rates of postpartum RD based on whether they delivered vaginally or via caesarean…
- New Retina Radio by Eyetube
Chronic Postoperative Inflammation: Patient Scenarios
How do retina specialists manage real-world patients with chronic postoperative inflammation? Host John Kitchens, MD, poses various scenarios to panelists…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Cost Evaluation in DME Therapy
Researchers performed a cost analysis of the DRCR Retina Network’s Protocol AC study comparing on-label and off-label anti-VEGF use in DME therapy. What did…
- New Retina Radio by Eyetube
How Imaging Helps Clinics Integrate New Therapies in GA
How do retina specialists introduce new therapies to patients, and how does thoughtful use of imaging help providers integrate new treatments into their…
New Retina Radio by EyetubeLuminaries in Retina: Kirk Packo, MD, FACS (Part 2)
In part 2 of this special podcast interview with John W. Kitchens, MD, and Kirk Packo, MD, FACS, they dive into Dr. Packo's involvement in the creation of AAO…
New Retina Radio by EyetubeLuminaries in Retina: Kirk Packo, MD, FACS (Part 1)
John W. Kitchens, MD, interviews Kirk Packo, MD, FACS, around his triumphant career and his decision to retire from practicing medicine following an unexpected…
- New Retina Radio by Eyetube
Chronic Postoperative Inflammation: Steroids’ Role in Treatment
How do retina specialists manage patients who present with postoperative inflammation following cataract surgery? Host John Kitchens, MD, and panelists Vaidehi…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Meta-analysis of PPV for Diabetic TRD
What did a meta-analysis of studies assessing the safety and efficacy of vitrectomy for diabetic tractional retinal detachment (TRD) find when it comes to the…
New Retina Radio by EyetubeASRS ’23: Pegcetacoplan Extension Study, and Comparison of Pegcetacoplan and Avacincaptad Pegol
New Retina Radio was at ASRS 2023 to cover the stories you may have missed. How did patients fare in the GALE extension study, which assessed the safety and…
- New Retina Radio by Eyetube
Chronic Postoperative Inflammation: Initial Encounters
What are the first steps retina specialists should take when a patient presents with postoperative inflammation? Host John Kitchens, MD, is joined by panelists…
- New Retina Radio by Eyetube
Imaging Geographic Atrophy: OCT, FAF, NIR, and OCTA
As we enter the therapeutic era of geographic atrophy, imaging the disease is more important than ever. How are retina specialists navigating this new clinical…
New Retina Radio by EyetubeASRS ’23: Missed Injections for AMD/DME/RVO and Anatomic Response to Vabysmo in Wet AMD
New Retina Radio was at ASRS 2023 to cover the stories you may have missed. How often do patients return to the clinic on time for anti-VEGF injections?…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Is Software on Home OCT as Good as Human Graders?
How often did human graders agree with software designed to detect and quantify retinal fluid in wet AMD patients using a home OCT prototype? Moderator Sabin…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Wet AMD: Fluid-free Visits' Association with Anatomic and Visual Outcomes
Were fluid-free visits correlated with outcomes in the HAWK/HARRIER studies? Moderator Katherine Talcott, MD, and panelists Kyle Kovacs, MD, and Rebecca…
New Retina Radio by EyetubeNew Retina Radio ARVO Coverage: DME Update: 8-mg Aflibercept data and Faricimab TAE in Phase 3
Is a solution to extending duration with aflibercept (Eylea, Regeneron) in DME patients an 8-mg dose rather than the typical 2-mg dose? Diana Do, MD, joined us…
New Retina Radio by EyetubeNew Retina Radio ARVO Coverage: Faricimab in Wet AMD: Real-world and Phase 3 Data
How are doctors using faricimab (Vabysmo, Genentech/Roche) in real-world settings? The IRIS Registry has a few answers. We sat down with Durga Borkar, MD…
- New Retina Radio by Eyetube
Treating GA In Your Clinic
After years of failed clinical trials, we finally have an approved therapy for geographic atrophy, and more are hopefully on the way. Allen C. Ho, MD, and…
New Retina Radio by EyetubeNew Retina Radio Journal Club: AMD and Depression Risk
What did an analysis of the Korean National Health Insurance Service database reveal about the link between age-related macular degeneration and depression…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Duration of Macular Detachment and Final Visual Prognosis
What does an analysis of the Japan-Retinal Detachment Registry reveal about the relationship between duration of macular detachment and visual prognosis?…
- New Retina Radio by Eyetube
The Utility of OCTA in the Clinic
Cynthia A. Toth, MD, and Amani A. Fawzi, MD, sit down with experts Philip J. Rosenfeld, MD, PhD; SriniVas Sadda, MD; and Nadia K. Waheed, MD, MPH, to discuss…
- New Retina Radio by Eyetube
The Era of Geographic Atrophy Treatment Begins
The FDA approval of pegcetacoplan (Syfovre, Apellis Pharmaceuticals) is a historic moment for the field of retina, finally providing a treatment option for…
- New Retina Radio by Eyetube
Inclusion Pearls and Pitfalls For Retina Specialists
Diversity and inclusion in medical practice is essential, and while retina specialists always have their patients’ and colleagues’ best interests at heart…
- New Retina Radio by Eyetube
Tips for Mastering Secondary IOLs
No two secondary IOL procedures are the same, and each case requires your full attention. What is your favorite technique? How are you protecting the haptics…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Profiling Punctate Inner Choroidopathy-like Reactions
Punctate inner choroidopathy-like, or PIC-like, reactions are rare, and they sometimesl confound retina specialists. New Retina Radio Journal Club with VBS…
New Retina Radio by EyetubeAAO '22: Biosimilars’ Practice Implications and Year 2 of YOSEMITE/RHINE
Two biosimilars have been approved by the US FDA, and more are going to receive approval soon. With this level of disruption in US retina practice, what do you…
- New Retina Radio by Eyetube
Innovations in Retinal Imaging
John Kitchens, MD, invites Aleksandra Rachitskaya, MD, and Jonathan Russell, MD, PhD, to discuss the use of imaging technology in the retina clinic. The…
New Retina Radio by EyetubeAAO '22 Late-Breaking Talks: Gene Therapies for GA and XLRP
We know about long-term intravitreal injections that might slow the progression of geographic atrophy (GA). But could a gene therapy in the pipeline require…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 Papers
Two biosimilars have been approved for retinal indications. What conclusions were drawn from the phase 3 studies that preceded their approval? Yasha Modi, MD…
New Retina Radio by EyetubeAAO '22: Biomarkers and AI in the OR
Identifying systemic biomarkers indicating risk for age-related macular degeneration would be a game-changer. But how can we find those biomarkers? We spoke…
New Retina Radio by EyetubeAAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE Update
Phase 3 data evaluating the biosimilarity of a new biosimilar (Xlucane, Xbrane Biopharma) referencing ranibizumab (Lucentis, Genentech) has been completed…
New Retina Radio by EyetubeAAO '22: GATHER2 Study Results
Researchers in the second pivotal study evaluating the safety and efficacy of avacincaptad pegol (Zimura, IVERIC bio) for the treatment of geographic atrophy…
- New Retina Radio by Eyetube
New Retina Radio Journal Club: Latest Literature in Stickler Syndrome and GRTs
What is the effect of laser prophylaxis in patients with Stickler Syndrome, and just how effective are buckles in patients with GRT detachments? Yoshi…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Updates in ROP
What changed in the most recent iteration of the International Classification of Retinopathy of Prematurity? And what do new data tell us about how ROP…
New Retina Radio by EyetubeASRS Meeting Coverage Day 3: DR Biomarkers and Gene Tx for Achromatopsia
Can a quantitative analysis of OCT images detect early diabetic retinopathy in patients without symptoms? New Retina Radio spoke with Jennifer Lim, MD, whose…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Multifocal, Indolent, Nonprogressive Choroidal Lesions
Retina specialists may wish to turn to the literature to learn more about multifocal, indolent, nonprogressive choroidal lesions. Let the New Retina Radio…
New Retina Radio by EyetubeASRS Meeting Coverage: Day 2
Was treat-and-extend faricimab (Vabysmo, Genentech) an effective means of controlling DME in the YOSEMITE and RHINE studies? New Retina Radio spoke with John…
New Retina Radio by EyetubeASRS Meeting Coverage: Day 1
Treat-and-extend regimens has been used for thousands of wet AMD patients. How does brolucizumab (Beovu, Novartis) stack up when compared with aflibercept…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Recurrent RRD Management
How might two recent contributions to the literature deepen our understanding of recurrent rhegmatogenous retinal detachment (RRD)? To find out, moderator Kyle…
New Retina Radio by EyetubeThe Life and Career of Steve Charles, MD, FACS, FICS, FASRS
In this episode, John W. Kitchens, MD, speaks with Steve Charles, MD, FACS, FICS, FASRS, a vitreoretinal surgeon and founder of the Charles Retina Institute in…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Pentosan Polysulfate Maculopathy
What are the latest findings regarding pentosan poloysulfate maculopathy (PPM)? Moderator Basil Williams, MD, invites panelists Karen Jeng-Miller, MD, MPH; M…
New Retina Radio by EyetubeARVO Meeting Coverage Day 3: CANDELA and ARCHWAY Data
Could an 8-mg dose intensify the therapeutic effect of aflibercept (Eylea, Regeneron) in patients with wet AMD? The phase 2 CANDELA study sought to explore the…
New Retina Radio by EyetubeARVO Meeting Coverage Day 2: Pipeline Therapies in GA
Could RPE cell replacement therapy be the future of GA treatments? Retina Today’s Chief Medical Editor Allen C. Ho, MD, joined us to discuss observations from…
New Retina Radio by EyetubeARVO Meeting Coverage Day 1: LIGHTSITE III and DERBY/OAKS at 18 Months
Could photobiomodulation soon be a therapeutic option for patients with dry AMD? Researchers in the LIGHTSITE III study are working toward finding out. We…
- New Retina Radio by Eyetube
New Treatment Options and Considerations for AMD
Anti-VEGF therapy has been a game changer for patients with AMD; now, the treatment toolbox is getting an overhaul with two new approvals and, hopefully, more…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Trends in Retina Reimbursement
How has reimbursement for common vitreoretinal procedures changed from 2011 to 2020? To find out, moderator Eric Nudleman, MD, PhD, hears from panelists John…
New Retina Radio by EyetubeNew Retina Radio Journal Club: Diversity in Clinical Trials
Do the demographics of patients enrolled in clinical trials accurately reflect the patient populations their drugs intend to treat? Moderator Basil Williams…
New Retina Radio by EyetubeNew Retina Radio Journal Club: PPV vs PnR for RRD
Pars plana vitrectomy (PPV) and pneumatic retinopexy (PnR) are both commonly employed to repair rhegmatogenous retinal detachment (RRD). What does the…
New Retina Radio by EyetubeArt of Drug Choice: Treating New Wet AMD Patients
Have innovations in therapy actually led to a paradigm shift when it comes to encountering patients with newly diagnosed wet AMD? In the season finale of “The…
New Retina Radio by EyetubeArt of Drug Choice: Who Is Best Suited for Extended-duration Therapy?
How do retina specialists decide which wet AMD patients are best suited for extended duration therapy and which patients should continue with more traditional…
New Retina Radio by EyetubeArt of Drug Choice: The Latest Advances in Wet AMD Therapy
How have the most recent advances in wet AMD therapy changed the treatment landscape for clinicians? In this debut episode of the third season of “The Art of…
New Retina Radio by EyetubeAnti-VEGF, A Biography: Part 3
This story started in the early days of VEGF's isolation in the 1970s and brought us to the discovery of ranibizumab and bevacizumab in the mid 2000s. The data…
New Retina Radio by EyetubeAnti-VEGF, A Biography: Part 2
New Retina Radio continues its biography of anti-VEGF. John D. Pitcher III, MD, picks up the story where we left off: in a world where pegaptanib was the only…
- New Retina Radio by Eyetube
Exploring the clinical development program for an innovative, continuous delivery treatment for nAMD
Recently, the first refillable, intraocular device that enables continuous delivery of therapy was FDA approved for nAMD. John Kitchens, MD sits down with one…
- New Retina Radio by Eyetube
Tackling PVR in the OR
In this roundtable moderated by Allen C. Ho, MD, and Robert L. Avery, MD, experts discuss the frustration of postoperative proliferative vitreoretinopathy and…
New Retina Radio by EyetubeAnti-VEGF, A Biography: Part 1
Many young retina specialists have always known retina as an anti-VEGF world. But how did this happen? John D. Pitcher III, MD, joins Scott and Ranna in studio…
- New Retina Radio by Eyetube
Perspectives on an innovative drug delivery system for nAMD: From training to initial experiences
Innovation often drives surgeons to adopt new techniques and surgical approaches. Join John Kitchens, MD, Carl Awh, MD, and Aleksandra Rachitskaya, MD as they…
New Retina Radio by EyetubeMatching Patients to Therapy in Wet AMD: Lifestyle Factors That Guide Treatment
In the culmination of this case-based series discussing who is best suited for which types of wet AMD therapy, John Kitchens, MD, invites Murtaza Adam, MD, and…
New Retina Radio by EyetubeMatching Patients to Therapy in Wet AMD: Deciding Who Is Best Suited for Long-Duration Treatments
In the second installment of this ongoing series covering wet AMD, Lisa Faia, MD, and Sumit Sharma, MD, submit to host John Kitchens, MD, a set of real-world…
New Retina Radio by EyetubeAAO 2021: Updates in Uveitis and Trauma
Changes to the uveitis treatment landscape after years of stagnation warrant a reset on what is approved, what the latest data are, and which developments are…
New Retina Radio by EyetubeMatching Patients to Therapy in Wet AMD: How New Technology May Alleviate Treatment Burden
In the first of this three-part series reviewing topics in wet AMD, Carl Regillo, MD, and Adrienne Scott, MD, join moderator John Kitchens, MD, to submit a…